Jazz Pharmaceuticals plc (JAZZ) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
Jazz Pharmaceuticals plc (JAZZ) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$2.23 BCurrent assets$3.97 BLiabilities(calculated)$6.28 BAssets$11.08 BNon-current liabilities$4.05 BNon-current assets$7.11 BEquity$4.80 BGross equity(calculated)$5.46 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsAccounts receivable, net of allowancesInvestmentsInventoriesOther current assetsPrepaid expensesIntangible assets, netGoodwillDeferred tax assets, netProperty, plant and equipment, netOther non-current assetsOperating lease assetsDeferred financing costsAccrued liabilitiesCurrent portion of long-term debtAccounts payableIncome taxes payableLong-term debt, less current portionDeferred tax liabilities, netOther non-current liabilitiesOperating lease liabilities, less current portionAdditional paid-in capitalRetained earningsCapital redemption reserveNon-voting euro deferred sharesCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilities (calculated)EquityGross equity (calculated)Accumulated other comprehensive lossAccrued liabilitiesAccrued liabilities$1.03 BCurrent liabilitiesCurrent liabilities$2.23 BCash and cash equivalentsCash and cash equivalents$1.62 BCurrent assetsCurrent assets$3.97 BCurrent portion of long-term debtCurrent portion of long-term debt$1.02 BLiabilities (calculated)Liabilities(calculated)$6.28 BAccounts receivable, net of allowancesAccounts receivable, net of allowances$880.90 MAccounts payableAccounts payable$128.50 MInvestmentsInvestments$580.00 MIncome taxes payableIncome taxes payable$55.90 MInventoriesInventories$443.00 MAssetsAssets$11.08 BNon-current liabilitiesNon-current liabilities$4.05 BOther current assetsOther current assets$244.50 MLong-term debt, less current portionLong-term debt, less current portion$3.34 BPrepaid expensesPrepaid expenses$200.00 MDeferred tax liabilities, netDeferred tax liabilities, net$528.90 MIntangible assets, netIntangible assets, net$4.03 BOther non-current liabilitiesOther non-current liabilities$140.90 MNon-current assetsNon-current assets$7.11 BEquityEquity$4.80 BOperating lease liabilities, less current portionOperating lease liabilities, less current portion$43.60 MGross equity (calculated)Gross equity(calculated)$5.46 BGoodwillGoodwill$1.80 BAdditional paid-in capitalAdditional paid-in capital$4.33 BDeferred tax assets, netDeferred tax assets, net$926.40 MProperty, plant and equipment, netProperty, plant and equipment, net$212.00 MRetained earningsRetained earnings$1.13 BOther non-current assetsOther non-current assets$86.30 MCapital redemption reserveCapital redemption reserve$500.00 KOperating lease assetsOperating lease assets$52.10 MNon-voting euro deferred sharesNon-voting euro deferred shares$100.00 KDeferred financing costsDeferred financing costs$6.60 MAccumulated other comprehensive lossAccumulated other comprehensive loss−$662.50 M
Chart details

Jazz Pharmaceuticals plc (JAZZ) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
11,080,900,000 US dollars
Current assets
3,968,200,000 US dollars
Non-current assets
7,112,700,000 US dollars
Liabilities (calculated)
6,279,200,000 US dollars
Current liabilities
2,230,800,000 US dollars
Non-current liabilities
4,048,400,000 US dollars
Equity
4,801,700,000 US dollars
Cash and cash equivalents
1,619,800,000 US dollars
Accounts receivable, net of allowances
880,900,000 US dollars
Investments
580,000,000 US dollars
Inventories
443,000,000 US dollars
Other current assets
244,500,000 US dollars
Prepaid expenses
200,000,000 US dollars
Intangible assets, net
4,029,500,000 US dollars
Goodwill
1,799,800,000 US dollars
Deferred tax assets, net
926,400,000 US dollars
Property, plant and equipment, net
212,000,000 US dollars
Other non-current assets
86,300,000 US dollars
Operating lease assets
52,100,000 US dollars
Deferred financing costs
6,600,000 US dollars
Accrued liabilities
1,030,000,000 US dollars
Current portion of long-term debt
1,016,400,000 US dollars
Accounts payable
128,500,000 US dollars
Income taxes payable
55,900,000 US dollars
Long-term debt, less current portion
3,335,000,000 US dollars
Deferred tax liabilities, net
528,900,000 US dollars
Other non-current liabilities
140,900,000 US dollars
Operating lease liabilities, less current portion
43,600,000 US dollars
Additional paid-in capital
4,331,600,000 US dollars
Retained earnings
1,132,000,000 US dollars
Capital redemption reserve
500,000 US dollars
Non-voting euro deferred shares
100,000 US dollars
Ordinary shares
0 US dollars
Accumulated other comprehensive loss
negative 662,500,000 US dollars
Gross equity (calculated)
5,464,200,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
Jazz Pharmaceuticals plc (JAZZ) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!